Trials / Completed
CompletedNCT00170924
To Find Out Whether Valsartan With or Without Other Blood Pressure Medications Would Improve the Ability of the Heart to Fill and Empty, and the Ability of the Heart Muscle to Relax Adequately in People With High Blood Pressure.
A Multi-center, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Effect of the Angiotensin II Antagonist Valsartan on Diastolic Function in Patients With Hypertension and Diastolic Dysfunction
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 317 (actual)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 45 Years
- Healthy volunteers
- —
Summary
Patients who have had high blood pressure for a long time may have diastolic dysfunction. Diastolic Dysfunction is when your heart has difficulty filling and emptying, and relaxing adequately. This study is to find out if Valsartan) will improve the ability of the heart to fill, empty, and relax appropriately when given alone or with other medicines to treat high blood pressure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Valsartan |
Timeline
- Start date
- 2004-08-01
- Primary completion
- 2006-06-01
- Completion
- 2006-06-01
- First posted
- 2005-09-15
- Last updated
- 2011-11-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00170924. Inclusion in this directory is not an endorsement.